RAC - Charts & Price Action, page-22055

5-10x from here is a failure of realisation in my opinion.

If RAC can dose people and thus, when CPACS is demonstrated (Does anybody doubt or object that we are going to see different in vivo [human] results, the fourth time?).

5-10x is the equivalent of going down to local car yard and trading in your 2013 ferrari for a 2023 corolla and being happy and believing you're a genius because you got a new car out of the deal.

Now that we are at the point end:
My target was $133/share years ago, i only eluded to $100+ over thebl years.
I based that primarily on the fact that at the time, that was the equivalent of Trudolvy buyout [ceiling].

Whilst Pfizers COVID cash injection eclipsed that ceiling, someone still needs to have the value to pony up for Bisantrene.
Fair value is truly ridiculous and probably not even achievable in a single transaction.